Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC)

被引:47
|
作者
Pavlov, Tengis S. [1 ]
Ilatovskaya, Daria V. [1 ,3 ]
Levchenko, Vladislav [1 ]
Mattson, David L. [1 ]
Roman, Richard J. [4 ]
Staruschenko, Alexander [1 ,2 ]
机构
[1] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA
[3] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia
[4] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA
基金
美国国家卫生研究院;
关键词
aldosterone; eicosanoids; 11,12-EET; 8,9-EET; 14,15-EET; 20-HETE; prostaglandins; RENAL COLLECTING DUCT; THICK ASCENDING LIMB; PROTEIN-KINASE-A; NA+ CHANNEL; PROSTAGLANDIN E-2; K-CHANNELS; DEPENDENT METABOLITES; CELL-SURFACE; TRANSPORT; CAMP;
D O I
10.1152/ajprenal.00597.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pavlov TS, Ilatovskaya DV, Levchenko V, Mattson DL, Roman RJ, Staruschenko A. Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC). Am J Physiol Renal Physiol 301: F672-F681, 2011. First published June 22, 2011; doi:10.1152/ajprenal.00597.2010.-Sodium reabsorption via the epithelial Na(+) channel (ENaC) in the aldosterone-sensitive distal nephron plays a central role in the regulation of body fluid volume. Previous studies have indicated that arachidonic acid (AA) and its metabolite 11,12-EET but not other regioisomers of EETs inhibit ENaC activity in the collecting duct. The goal of this study was to investigate the endogenous metabolism of AA in cultured mpkCCD(c14) principal cells and the effects of these metabolites on ENaC activity. Liquid chromatography/mass spectrometry analysis of the mpkCCD(c14) cells indicated that these cells produce prostaglandins, 8,9-EET, 11,12-EET, 14,15-EET, 5-HETE, 12/8-HETE, and 15-HETE, but not 20-HETE. Single-channel patch-clamp experiments revealed that 8,9-EET, 14,15-EET, and 11,12-EET all decrease ENaC activity. Neither 5-, 12-, nor 15-HETE had any effect on ENaC activity. Diclofenac and ibuprofen, inhibitors of cyclooxygenase, decreased transepithelial Na(+) transport in the mpkCCD(c14) cells. Inhibition of cytochrome P-450 (CYP450) with MS-PPOH activated ENaC-mediated sodium transport when cells were pretreated with AA and diclofenac. Coexpression of CYP2C8, but not CYP4A10, with ENaC in Chinese hamster ovary cells significantly decreased ENaC activity in whole-cell experiments, whereas 11,12-EET mimicked this effect. Thus both endogenously formed EETs and their exogenous application decrease ENaC activity. Downregulation of ENaC activity by overexpression of CYP2C8 was PKA dependent and was prevented by myristoylated PKI treatment. Biotinylation experiments and single-channel analysis revealed that long-term treatment with 11,12-EET and overexpression of CYP2C8 decreased the number of channels in the membrane. In contrast, the acute inhibitory effects are mediated by a decrease in the open probability of the ENaC. We conclude that 11,12-EET, 8,9-EET, and 14,15-EET are endogenously formed eicosanoids that modulate ENaC activity in the collecting duct.
引用
收藏
页码:F672 / F681
页数:10
相关论文
共 50 条
  • [31] Cytochrome P450-dependent metabolites of arachidonic acid and renal function in the rat
    Oyekan, AO
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (08) : 581 - 586
  • [32] Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid
    Maier, KG
    Henderson, L
    Narayanan, J
    Alonso-Galicia, M
    Falck, JR
    Roman, RJ
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (02): : H863 - H871
  • [33] DILATION OF CEREBRAL ARTERIOLES BY CYTOCHROME-P-450 METABOLITES OF ARACHIDONIC-ACID
    ELLIS, EF
    POLICE, RJ
    YANCEY, L
    MCKINNEY, JS
    AMRUTHESH, SC
    AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (04): : H1171 - H1177
  • [34] Cytochrome P450 arachidonic acid metabolites modulate renal tubular function
    Carroll, MA
    Ferreri, NR
    Escalante, BA
    Oyekan, AO
    McGiff, JC
    ADVANCES IN PROSTAGLANDIN, LEUKOTRIENE, AND OTHER BIOACTIVE LIPID RESEARCH: BASIC SCIENCE AND CLINICAL APPLICATIONS, 2003, 525 : 67 - 69
  • [35] Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid
    Ito, O
    Omata, K
    Ito, S
    Hoagland, KM
    Roman, RJ
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (03) : R822 - R830
  • [36] CARDIOVASCULAR AND RENAL ACTIONS OF CYTOCHROME-P-450 METABOLITES OF ARACHIDONIC-ACID
    PROCTOR, KG
    CAPDEVILA, JH
    FALCK, JR
    FITZPATRICK, FA
    MULLANE, KM
    MCGIFF, JC
    BLOOD VESSELS, 1989, 26 (01): : 53 - 64
  • [37] Altered release of cytochrome P450 metabolites of arachidonic acid in renovascular disease
    Minuz, P.
    Jiang, H.
    Fava, C.
    Turo, L.
    Tacconelli, S.
    Ricci, M.
    Patrignani, P.
    Morganti, A.
    Lechi, A.
    McGiff, J. C.
    JOURNAL OF HYPERTENSION, 2007, 25 : S396 - S396
  • [38] Cytochrome P450 metabolites of arachidonic acid: novel regulators of renal function
    Hoagland, KM
    Maier, KG
    Moreno, C
    Yu, M
    Roman, RJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (12) : 2283 - 2285
  • [39] ACTIVATION OF K+-CHANNEL IN VASCULAR SMOOTH MUSCLES BY CYTOCHROME-P450 METABOLITES OF ARACHIDONIC-ACID
    HU, SL
    KIM, HS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (02) : 215 - 221
  • [40] Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect
    Rastaldo, R
    Paolocci, N
    Chiribiri, A
    Penna, C
    Gattullo, D
    Pagliaro, P
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (06): : H2823 - H2832